Sandra Bright

Clinical Assessor, HPRA (Health Products Regulatory Authority)

Sandra Completed an honours Science degree in 2005, specialising in Biochemistry and Immunology in Trinity College Dublin, Ireland. She also completed research PhD in Oncology and Drug Development in 2009 (relating to Chronic myeloid leukaemia, CML) in Trinity College Dublin, Ireland. Sandra has also worked in academia research for a number of years: in the field of oncology (solid and haematological malignancies), drug design, in vitro testing, in vivo animal work Currently a clinical assessor in the HPRA: assessing new licence applications (centralised, DCP, MRP) and variations, clinical trial application and amendments, annual safety reports (DSURs) and scientific advice (national and EU level) and an Irish representative at the EU regulatory meeting group: CTFG (Clinical Trials Facilitation and Co-ordination Group)